Nora Rabah

Nora Rabah has worked in various roles and companies over the years, starting with their current position as Associate Director of Corporate Strategy & Market Planning at Alector, which they began in June 2022. Before that, they worked as a Commercial (Marketing) Summer Associate at Genentech from May to August 2021. From August 2019 to February 2021, Nora worked as a Commercial Strategy & Operations Associate at Sio Gene Therapies. Prior to that, they were a Commercial Investments Analyst at Roivant Sciences from February 2019 to July 2020. Nora also has experience as an Investment Banking Analyst at MTS Health Partners, L.P., starting in July 2018 and ending in January 2019. In June to August 2017, they worked as an Investment Banking Summer Analyst at the same company. Nora's work experience started in June to August 2016 as a Business Development Intern at BioMotiv.

Nora Rabah has a diverse education history. Nora obtained a Master of Business Administration (MBA) degree from Harvard Business School. Prior to that, they completed their Bachelor of Science (B.S.) degree summa cum laude at Cornell University, majoring in Biology and Society with minors in Health Policy and Science and Technology. Nora also holds a Master of Science (MS) degree from the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences, specializing in Biotechnology. Nora achieved the distinction of being the Valedictorian of Whitney High School. Additionally, they have obtained certifications such as the Series 63 and Series 79 from the FINRA (Financial Industry Regulatory Authority).